Press Releases

Lophos Pharmaceuticals Submits Application for Controlled Drugs and Substances Dealer’s License

by in Press Releases February 17, 2022

TORONTO, Feb. 17, 2022 (GLOBE NEWSWIRE) — Lophos Holdings (The “Company”) is pleased to provide an update on its wholly owned subsidiary Lophos Pharmaceuticals (“Lophos”). Lophos is a psychedelic research company primarily focused on novel therapeutic treatments derived from Peyote (Lophophora williamsii). Lophos has made significant strides in launching operations at their recently acquired 10,000 square foot […]

G2 Acquires Lophos Pharma, a peyote focused psychedelics company

by in Press Releases January 21, 2022

TORONTO, Jan. 21, 2022 (GLOBE NEWSWIRE) — Greenridez 2.0 Acquisitions Corp. (the “Company“) is pleased to announce that it has completed its acquisition of psychedelic research company Lophos Pharma (“Lophos”). Lophos Pharma is a psychedelic research company primarily focused on novel therapeutic treatments derived from Peyote (Lophophora williamsii). The Company strongly supports Lophos Pharma’s belief in Peyote’s […]